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Abstract
Background: NET1, a RhoA guanine exchange factor, is up-regulated in gastric cancer (GC) tissue and drives the
invasive phenotype of this disease. In this study, we aimed to determine the role of NET1 in GC by monitoring the
proliferation, motility and invasion of GC cells in which NET1 has been stably knocked down. Additionally, we
aimed to determine NET1-dependent transcriptomic events that occur in GC.
Methods: An in vitro model of stable knockdown of NET1 was achieved in AGS human gastric adenocarcinoma
cells via lentiviral mediated transduction of short-hairpin (sh) RNA targeting NET1. Knockdown was assessed using
quantitative PCR. Cell proliferation was assessed using an MTS assay and cell migration was assessed using a
wound healing scratch assay. Cell invasion was assessed using a transwell matrigel invasion assay. Gene expression
profiles were examined using affymetrix oligonucleotide U133A expression arrays. A student’s t test was used to
determine changes of statistical significance.
Results: GC cells were transduced with NET1 shRNA resulting in a 97% reduction in NET1 mRNA (p < 0.0001).
NET1 knockdown significantly reduced the invasion and migration of GC cells by 94% (p < 0.05) and 24% (p <
0.001) respectively, while cell proliferation was not significantly altered following NET1 knockdown. Microarray
analysis was performed on non-target and knockdown cell lines, treated with and without 10 μM lysophosphatidic
acid (LPA) allowing us to identify NET1-dependent, LPA-dependent and NET1-mediated LPA-induced gene
transcription. Differential gene expression was confirmed by quantitative PCR. Shortlisted NET1-dependent genes
included STAT1, TSPAN1, TGFBi and CCL5 all of which were downregulatd upon NET1 downregulation. Shortlisted
LPA-dependent genes included EGFR and PPARD where EGFR was upregulated and PPARD was downregulated
upon LPA stimulation. Shortlisted NET1 and LPA dependent genes included IGFR1 and PIP5K3. These LPA induced
genes were downregulated in NET1 knockdown cells.
Conclusions: NET1 plays an important role in GC cell migration and invasion, key aspects of GC progression.
Furthermore, the gene expression profile further elucidates the molecular mechanisms underpinning NET1-
mediated aggressive GC cell behaviour.
Background
Gastric Cancer (GC) is a significant oncological “pro-
blem” as it is characterised by a high metastatic poten-
tial and a dismal 5-year survival rate of 20%. The
disease often presents at an advanced stage, often with
lymph node or distant metastases, and patients therefore
generally have a poor outcome [1,2]. There is a poor
understanding of the natural history of the disease and
despite advances in surgery, surgical cure is rare.
Conventional chemotherapeutic approaches to dealing
with GC are limited and often ineffective. Recent work
has identified molecular markers may correlate with dis-
ease recurrence following surgery [3,4] and with
response to chemotherapy [5]. There is however, a real
need to further understand the biology of this disease in
order to develop effective targeted therapies. Novel med-
iators of the disease process, and novel interactions
between existing and established mediators, have been
identified by our group [6,7]. We propose that inhibition
of the molecular mechanisms we have defined may lead
to improved therapies for GC patients.
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(GEF) for RhoA, is up-regulated in GC tissue and drives
its aggressive phenotype. The GEF family of proteins
activate GTPases such as RhoA, leading to downstream
signalling. NET1 is upregulated by Lysophosphatidic
Acid (LPA), a known activator of RhoA, and
NET1 drives cancer cell migration, invasion and cytos-
keletal actin organisation [7]. In order to further exam-
ine the role of NET1 in the disease setting, we created a
unique Human Caucasian gastric adenocarcinoma
(AGS) cell line with stablek n o c k d o w no fN E T 1 .T h i s
model was used to investigate the role of NET1 in cell
proliferation, migration and invasion assays but also to
fully identify the downstream transcriptomic events,
t h e r e b ya l l o w i n gau n i q u ei n s i g h ti n t ot h eg e n e so f
importance in GC cell invasion.
Many GC microarray studies have focussed on the
identification of genes dysregulated in GC tissue in
comparison to normal gastric tissue with the aim of
developing an “expression profile” for GC cells [8-12],
Hasegawa et al have proposed a 12 gene signature that
correlates with lymph node involvement in GC [8].
Gene expression profiles generated by microarray have
been used to develop prognostic scores, which when
coupled with clinical parameters, have proven useful in
predicting aggressive GCs and ultimately, outcome [13].
More recently microarray technology has been employed
in the determining survival after resection [14], response
to chemotherapy [15,16] and changes in gastric mucosa
caused by Helicobacter pylori [17-19]. In this study,
using our novel “NET1 knockdown” cell line, microar-
rays were used to identify NET1 dependent transcrip-
tomic events. We hypothesise that the gene expression
profile observed supports the putative pathogenic role of
NET1 in GC migration and invasion.
Methods
Cell Culture and Short hairpin RNA (shRNA) Transduction
Human Caucasian gastric adenocarcinoma cells (AGS
cells) were purchased from the European Collection of
Cell Cultures (ECACC) and cultured in Hams
F12 medium (Sigma Aldrich), supplemented with 10%
fetal bovine serum (FBS), L-glutamine and Penicillin-
Streptomycin (Sigma Aldrich), as per ECACC recom-
mendations and incubated at 37°C and 5%CO2.
MISSION™ shRNA Lentiviral Transduction Particles
(Sigma Aldrich) were used to achieve stable
NET1 knockdown. 5 NET1 specific shRNA constructs
(named constructs 63, 64, 65, 66 and 67), and one “non
target” construct were transduced separately into AGS
cells. The “non target” construct contained a short hair-
pin RNA sequence which did not code for any known
human gene, and acted as a control. Briefly, AGS cells
were incubated with the NET1-specific shRNA lentiviral
particles at a ratio of 2 particles to 1 cell, in the pre-
sence of hexadimethrine bromide to improve transduc-
tion efficiency. “Non target” shRNA lentiviral particles
were used to control for the effects of the transduction
process itself. Successfully transduced cells included a
puromycin resistance tag, and these cells were selected
using 1 μg/ml puromycin. NET1 knockdown was con-
firmed using quantitative RTPCR and western blot ana-
lysis. For the remainder of this study, three distinct cell
types were used; NET1 wild type cells (AGS cells which
had not been transduced), NET1 knockdown cells (AGS
cells transduced with NET1 targeting shRNA) and non-
target shRNA cells (transduced with scrambled shRNA
which did not target any gene).
RNA extraction and PCR
RNA extraction by Trizol™,( S i g m aA l d r i c h ,I r e l a n d )
and reverse transcription were performed as previously
described [6]. PCR was performed using Quantitect™
Sybr Green PCR kit (Qiagen™) according to the manu-
factures instructions. Briefly, 1 μl cDNA was mixed with
6.25 μl of Sybr Green, 4.25 μl DNase free water, and
0.5 μl of forward and reverse primer. The reaction was
carried out using a Rotor Gene™ 3000 system. All
experiments were carried out in duplicate. b-actin
mRNA expression was used to normalize and compare
expression values for genes of interest.
Cell Proliferation Assay
Cell proliferation was assessed by adding 100 μl contain-
ing 1 × 10
4 cells to three wells of a 96 well plate. Fol-
lowing incubation for 24 hr in serum starved conditions,
with or without 10 μML P A ,2 0μlo fM T Sr e a g e n tw a s
added, and following 2 hr incubation at 37°C, 5%CO2,
absorbance was read at 490 nm using a microplate
reader. Three wells containing no cells and MTS only,
were used as a blank. All analysis was repeated in tripli-
cate - i.e. on three separate occasions.
Cell migration
Migration was assessed by wound healing scratch assay
as previously described [7]. NET1 knockdown cells
(clone 65b), control non target cells and wild type AGS
cells were seeded in duplicate wells of a six well plate
and grown to 100% confluence. A vertical wound was
created in the cell monolayer in each well using a sterile
P10 micropipette tip. The wells were then washed with
1m lo fg r o w t hm e d i u m ,w h i c hw a sr e m o v e da n d
replaced with 3 mls of serum free growth medium.
The first image of each scratch was acquired at time
zero through a phase contrast microscope at 10× magni-
fication. The 6 well plate was then incubated at 37°C,
5% CO2 for 14 hours. At 14 hours, each scratch was
examined and photographed at the same location. The
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24 hours, then removed and photographed again at the
same reference point for each scratch. The images
acquired for all 3 cell types were compared. The area of
the scratch on the 0 hour image was marked by outlin-
ing the area that was free from cells, forming a rectangle
that was subsequently superimposed on the 14 hour and
24 hour images. The total number of cells migrating
into the marked area at 14 and 24 hours were counted.
All analysis was repeated in triplicate.
Invasion assay
Biocoat matrigel invasion chambers were used to compare
the effect of NET1 knockdown on in vitro invasion of
AGS cells as previously described [6]. Briefly, 500 μlo f
serum free media containing 1 × 10
5 cells of each type -
knockdown cells (clone 65b), control non target cells, wild
type AGS cells was added into the upper chambers in
duplicate and allowed to invade into a lower chamber con-
taining Hams F12 media with 20% FBS by incubating for
24 hr at 5% CO2 37°C. Invasive cells were fixed, stained
and counted. All experiments were performed in triplicate.
Microarray Analysis
As described, AGS cells underwent short hairpin
mediated NET1 knockdown using 5 different shRNA
constructs targeting NET1. A scrambled non-target
shRNA was also used as a control. All transduced cells
were maintained separately according to the short hair-
pin RNA construct used for transduction. Biological
replicates were made for each construct (five
NET1 knockdown cell lines plus one non target control
cell line), producing 12 new GC cell lines. Three of those
novel cells lines were chosen for further investigation
using microarray: Control non target (NT) cells,
NET1 knockdown cells “63”,a n d“65”. Cells were cul-
tured in duplicate (e.g 63A and 63B) from the time of
initial transduction (biological replicates). Prior to mRNA
extraction using the Trizol™ method, all three chosen
cell lines (63, 65 and non target) were stimulated by
10 μM lyspohosphatidic acid (LPA) a known activator of
RhoA [7]. mRNA was therefore available from all 3 cell
types in their resting and stimulated states. In total,
mRNA was extracted from 12 distinct cell populations.
Prior to hybridisation, RNA quality was determined
using Agilent 2100™ bioanalyser. The quality of RNA was
determined by its RNA integrity number (RIN) which is
an estimate of the integrity of total RNA samples. RIN
values range from 10 (intact RNA) to 1 (totally degraded)
[20]. All 12 RNA samples were intact and of sufficient
quality to progress to the test chip stage (data not shown).
All 12 samples were successfully arrayed. Image files (.
cel) were obtained through Affymetrix GeneChip
software (MAS5) and were analysed using robust multi-
chip analysis (RMA) express software. Each array was
normalised individually, followed by normalisation
across all arrays to allow comparison. Only those probe
sets with an RMA value of greater than 5.0 were used
for further analysis [21,22]. The experimental data for
each group was averaged and the change in expression
was calculated by comparison of the signal log ratio
(SLR) from each sample group vs its control group. A
mean signal log ratio (SLR) of 0.6 or greater (equivalent
to a 1.5 or greater fold change in expression) as well as
a students t test output of < 0.005 were used to identify
significant differential expression.
Cluster analysis of the RMA normalised data was used
to group genes with similar patterns of expression, as
described in Eisen et al 1998 [23]. Correspondence ana-
lysis was used to identify major trends in datasets
[24,25]. DAVID EASE online tools were used to func-
tionally classify differentially expressed genes. The
expression of short listed genes was confirmed using
RTPCR as described above.
Statistical analysis
Data are expressed as mean +/- standard deviation from
triplicate experimental replicates and were analysed with
Microsoft Excel using Student’s t-test with significance
defined as p < 0.05
Results
Validation of NET1 knockdown
Following transduction, NET1 knockdown was con-
firmed by Reverse Transcriptase RT PCR by comparing
NET1 mRNA expression levels in cells transduced with
NET1 targeting shRNA, versus control cells (transduced
with non targeting shRNA) (Figure 1A). NET1 mRNA
expression was reduced in all cell lines when compared
to control non targeting control cells (P < 0.05). Exact
levels of NET1 suppression and p values, indicating sig-
nificance, are shown in Figure 1B. Clone 65b, which
showed the greatest reduction in NET1 mRNA expres-
sion was used for the functional studies herein.
Effect of NET1 knockdown on GC Proliferation in vitro
Following confirmation of knockdown, the proliferative
capacities of cells were compared using an MTS assay.
There was no significant difference between the prolif-
eration of AGS (clone 65b) cells transduced with
NET1 targeting shRNA versus control cells transduced
with non-targeting shRNA. Furthermore, transduction
with either non-targeting or NET1-specific shRNA had
no significant effect on AGS GC cell proliferation com-
pared to wild type non-transduced cells (Data not
shown).
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Following knockdown, we compared the migration of (i)
wild type non-transduced AGS cells (ii) non-targeting
scrambled shRNA transduced control cells and (iii)
NET1 knockdown cells transduced with NET1 targeting
shRNA (clone 65b). This was done using a scratch
assay. At 14 hours, migration was not significantly dif-
ferent between AGS wild type non transduced cells and
control cells transduced with non targeting scrambled
shRNA, as shown in Figure 2A. At 24 hours the migra-
tion of NET1 knockdown cells (clone 65b) was signifi-
cantly reduced compared to control cells transduced
with non targeting shRNA and to wild type cells (231 vs
296 vs 285 cells) P < 0.05 (Figure 2A).
Effect of NET1 knockdown on GC cell invasion in vitro
Following knockdown, cell invasion was assessed using
trans-well matrigel invasion inserts. Following
NET1 knockdown a 91% reduction in the invasion of
AGS cells (clone 65b) was observed, in comparison with
the invasion of cells transduced with non-targeting
shRNA (p < 0.005) (Figure 2B). The invasion of control
cells transduced with non targeting shRNA, which had
unchanged levels of NET1, was not significantly differ-
ent from the wild type non-transduced AGS cells.
Transcriptomic Effect of NET1 knockdown
For array comparisons, a standard error of the mean
was calculated for each dataset as shown in Figure 3A.
A standard error of the mean of ≤ 0.5 was taken as evi-
dence of sufficient similarity between arrays to allow
their inclusion for further analysis. As shown in
Figure 3A, all samples showed a similar range of distri-
bution and were therefore deemed comparable.
Using correspondence analysis, the arrays separated
into two distinct groups reflecting the presence or
absence of LPA stimulation by 10 μM LPA (Figure 3B).
We shortlisted genes with 1.5 fold change in expres-
sion and a p value less than 0.05. Three separate com-
parisons were made using the array data.
NET1 dependent gene changes were identified by com-
paring NET1 knockdown with control (transduced with
non targeting shRNA) samples. In this group, 148 genes
were significantly dysregulated (93 upregulated, 55 down-
regulated) (Figure 4A).
To determine LPA driven gene changes, we compared
the gene expression profiles of cells transduced with
non-targeting scrambled shRNA treated with and with-
out LPA and observed significant dysregulation of >
2000 genes, with approximately equal numbers of genes
up- (1087) and downregulated (1037). (Figure 4A).
Finally, we identified NET1-dependent LPA-driven
gene expression events by comparison of the expression
profiles of (i) LPA-stimulated control cells transduced
N
o
r
m
a
l
i
z
e
d
 
N
E
T
1
 
m
R
N
A
 
e
x
p
r
e
s
s
i
o
n
 
**
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
**
**
** **
6
7
a
6
6
a
6
5
a
6
3
a
6
3
b
6
4
a
6
7
b
6
6
b
6
5
b
6
4
b
n
o
n
t
a
r
g
e
t
construct used for knockdown
Figure 1 Confirmation of NET1 knockdown.F i g u r e1 A ;N E T 1
mRNA expression in AGS gastric cancer cells following transduction
with non-targeting scrambled shRNA (control cells) or separate
NET1 targeting shRNA molecules. Five separate NET1 targeting
shRNA molecules were transduced (denoted; 63, 64. 65. 66 & 67) in
duplicate (a & b). All values are expressed relevant to ‘non target’
control cells, given a value of 1. *p < 0.05 Figure 1B The percentage
NET1 mRNA knockdown achieved in AGS cells in comparison with
control cells transfected with non-targetting shRNA as determined
by RT PCR. Non target cells were given a value of 1 (100% NET1
expression) and all other values were compared to the control
sample. *P < 0.05.
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Figure 2 The role of NET1 in gastric cancer cell migration and
invasion. Figure 2A. The effect of NET1 knockdown on AGS gastric
cancer cell migration in vitro. Cell migration is expressed as
numbers of migrating (i) AGS wild type cells, (ii) control cells
tranduced with non targeting shRNA (NT) and (iii) NET1 knockdown
cells transduced with NET1 targeting shRNA (65b) at 14 and 24 hr
are represented. *p < 0.05. Error bars represent standard deviation
of triplicate experiments. Figure 2B: The in vitro invasion of AGS, NT
and NET1 knockdown cell line (65b). Invasion was expressed as
number of invading cells per 10X field. Error bars represent standard
deviation of triplicate experiments. *p < 0.0005.
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down cells transduced with NET1-targeting shRNA. We
observed 159 differentially genes expressed with
18 genes significantly downregulated. (Figure 4A).
For each of the three categories, a list of differentially
expressed genes was compiled. These lists were divided
into upregulated and downregulated genes for each cate-
gory. Using DAVID (Database for Annotation, Visualisa-
tion and Integrated Discovery) online software, the
functional categories of the genes were assigned.
(Figure 5).
With high levels of NET1, upregulation of genes
involved in cell proliferation, adhesion, cell motility, che-
motaxis, and cytoskeletal organisation was demonstrated
(Figure 5A upper panel). In contrast, higher levels of
NET1 were associated with downregulation of genes
involved in regulation of apoptosis, cell death and DNA
repair. (Figure 5A lower panel).
The LPA transcriptome demonstrated differential
expression of over 2000 genes, the most abundant func-
tional families are displayed in Figure 5B.
Using a combination of the above comparisons we
identified gene changes that are driven by LPA but also
dependent on NET1 (Figure 5C). Genes involved in
metabolic processes, cell cycle regulation, transcription
and cell growth were upregulated. (Figure 5C upper
panel). Relatively few downregulated genes were
detected, those that were related primarily to metabo-
lism. (Figure 5C lower panel).
Confirmation of Microarray analysis by RT PCR
Several genes from each category were chosen for further
analysis as shown in Figure 6. From the NET1 dependent
upregulated genes, STAT1, TSPAN1, TGFbIa n d
CCL5 were chosen. From the LPA dependent upregu-
lated genes, EGFR and PPARδ were selected for further
analysis. Finally IGF1R and PIP5K3 were chosen from
the NET1 dependent LPA driven upregulated genes. Real
time PCR was performed using gene specific primers. All
observations made by gene array experiments were con-
firmed using real time PCR (Figure 6).
Discussion
NET1 has been shown to be involved in the progres-
sion of GC [6]. NET1 is a known activator of Rho A,
and its actions, are at least in part RhoA mediated. In
this current study, a GC cell line with stable low levels
of NET1 expression was created to further investigate
its role in the disease process by assessing the
functional and global transcriptomic effects of this
knockdown.
Previous studies have shown that other guanine
exchange factors, such as GEFT, promote cellular prolif-
eration [26,27]. In this study proliferation was not
affected when NET1 was suppressed, suggesting that it
is not critical for the proliferation of GC cells. We have
previously shown the proliferation of GC cells to be
reduced 48 hr following transient transfection of
NET1 targeting siRNA [6]. In this current study, the
Figure 3 Data output from transcriptomic analyses. Figure 3A: Box plots following normalisation of gene array data sets. This Figure shows
the spread of data for each individual array. Figure 3B: Correspondence analysis of gene array data from cells treated with or without LPA.
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reduced via lentiviral mediated transduction of
NET1 targeting shRNA was assessed many cell passages
later. These data illustrate that NET1 is not essential for
AGS cell proliferation and the importance of establish-
ing stable long term knockdown models in order to
truly assess gene function.
Other guanine nucleotide exchange factors such as
Tiam1 have been shown to increase migration and inva-
sion of cancer cells, such as breast and colon cancer
[28-30]. In our study, migration was assessed using
wound healing assays. Significantly fewer
NET1 knockdown cells migrated across the scratch
when compared to wild type AGS cells and control non
target cells (P < 0.05). This reduction in migration was
not seen when the non target cells were compared to
the wild type AGS cells, supporting the hypothesis that
the motility of the cells was in part NET1 dependent.
When invasion of these cells was compared, the
NET1 knockdown cells displayed dramatically decreased
invasion compared to control cells transduced with non
targeting scrambled shRNA cells. The non target cells,
which serve as a control for the transduction process,
did not show a significant difference in invasion when
compared to the AGS cells. These results further sup-
port a central role for NET1 in GC cell migration and
invasion.
In this study, we successfully performed oligonucleo-
tide microarrays on NET1 knockdown cells and control
GC cells transduced with non targeting shRNA. We
identified 3 specific GC related expression patterns -
NET1 dependent gene changes, LPA driven gene
changes, and NET1 dependent LPA driven events. We
further identified the NET1 dependent pathways and
cellular processes through identification of the func-
tional classification of the differentially expressed genes.
Our microarray analysis showed that gene families relat-
ing to cell motility, chemotaxis and cytoskeletal organi-
sation were upregulated in the presence of high levels of
NET1. This supports previous data showing NET1 to be
involved in cytoskeletal reorganisation and cellular moti-
lity [7]. We have also demonstrated that genes involved
in regulation of apoptosis, cell death and DNA repair
are down-regulated in the presence of high levels of
NET1. As these traits are vital to cellular proliferation in
the cancer setting, these data support a role for NET1 as
a suppressor of these pathways.
LPA is a potent signalling molecule, that plays a key
role in driving angiogenesis and metastasis [31,32]. We
have previously shown LPA to drive RhoA activation in
GC, and furthermore, that NET1 mediates this process
[7]. Furthermore, we have previously shown the func-
tional effect of LPA in GC whereby treatment with LPA
resulted in an increase in AGS GC cell invasion and
Cell name  NET 1 LPA
stimulation
Control “NT A”  Normal +  Stimulated + 
Control “NT A”  Normal +  Unstimulated - 
Control “NT B”  Normal +  Stimulated + 
Control “NT B”  Normal +  Unstimulated - 
Knockdown “63A”  Reduced -  Stimulated + 
Knockdown “63A”  Reduced -  Unstimulated - 
Knockdown “63B”  Reduced -  Stimulated + 
Knockdown “63B”  Reduced -  Unstimulated - 
Knockdown “65A”  Reduced -  Stimulated + 
Knockdown “65A”  Reduced  -  Unstimulated - 
Knockdown “65B”  Reduced  -  Stimulated + 
Knockdown “65B”  Reduced  -  Unstimulated - 
Net1 dependent 
gene expression 
(63A+B)+ (65A+B) without LPA 
vs (NT A+B) without LPA 
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Figure 4 Data output from transcriptomic analyses and outline
of experimental design. Figure 4A: Global transcriptomic response
in each array experiment displaying the number of up and down
regulated genes in each array comparison (upper panel). 4B: The
unique cell lines from which RNA was extracted for microarray
analysis. RNA was extracted from each of the 3 experimental cell
lines, control ‘non target’ cells and knockdown 63 and 65, in
duplicate, from cells in resting and stimulated (10 μM LPA) states
(center panel). 4C: Microarray data comparisons to determine (1)
NET1 dependent transcription, (2) LPA dependent transcriptionand
(3) NET1 mediated LPA dependent genetic events (lower panel).
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control and NET1 knockdown cells in our gene array
studies to identify what LPA driven gene changes are
NET1 dependent. In this study, stimulation of AGS cells
with LPA resulted in the differential expression of over
2000 genes, the majority of which were involved in cel-
lular metabolic processes.
We shortlisted genes from each microarray comparison
for quantitative Real Time PCR validation. This was done
to ensure these genes were not falsely identified by gene
a r r a yb u ta l s ob e c a u s et h e yw e r er e l a t e dt oc e l lf u n c t i o n si n
which NET1 is established e.g. chemotaxis, or they were
related to GC, a disease wherein NET1 plays an important
role. STAT1 (signal transducer and activator of transcrip-
tion 1) was up-regulated in AGS cells with high levels of
NET1 in comparison with NET1 knockdown cells. We
shortlisted STAT1 as recent evidence has emerged sup-
porting a role for it in gastric inflammation and tumorigen-
esis in mice [33-36]. In this study TSPAN1 mRNA
expression levels correlated with NET1 with decreased
expression in NET1 knockdown cells. TSPAN1 is upregu-
lated in oesophageal, ovarian and endometrial cancers
[37-39]. TSPAN1 is overexpressed in GC where it corre-
lates negatively with the degree of tumour differentiation
and survival, and positively with depth of invasion and
lymph node involvement [40]. TGFBi inhibits cell adhesion
and correlates with advanced metastasis in colorectal can-
cer [41]. We have shown a clear relationship between
NET1 expression and TGFBi expression, with negligible
TGFBi expression detected in NET1 knockdown cells.
CCL5 (Chemokine ligand 5) expression levels have been
shown to correlate with poor outcome in GC [42]. While
its role in GC remains to be fully elucidated, we have
shown that NET1 is important for expression of CCL5 in
GC.
In this study, we have shown by microarray and
RTPCR that EGFR, a cell surface receptor for members
of the EGF family is up regulated upon LPA treatment.
EGFR is known to be crucial for cancer cell survival and
differentiation [43] and is therefore a target for cancer
therapy [44,45] using EGFR inhibitors. In this study we
s h o r t l i s t e dE G F Ra sL P Aa n dE G F Ri n t e r p l a yh a s
recently been shown to promote GC cell motility and
invasion [46]. In this study we have shown that PPARD
expression was down regulated in AGS cells treated
with LPA. PPARD has been shown to be associated with
colonic tumorigenesis in mice [47]. PPARD expression
has been described in squamous head and neck cancers
[48] and in endometrial cancer [49]. LPA has been
described as an activator of PPAR gamma, though no
reports of LPA induction or inhibition of PPARD have
yet been published.
Figure 5 Functional classification for differentially expressed genes. Figure 5A: Functional annotation of NET1 dependent upregulated
(upper panel) and downregulated (lower panel) genes. Figure 5B: Functional annotation of LPA dependent upregulated (upper panel) and
downregulated (lower panel) genes. Figure 5C: Functional annotation of NET1 and LPA dependent upregulated (upper panel) and
downregulated (lower panel) genes. Total gene count is represented on the Y axis.
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Figure 6 Validation of gene array findings by real time PCR. Figure 6A: STAT 1 mRNA expression in control cells transduced with non targeting
shRNA (NT) [shown in all diagrams in Figure 6 as NET1 (+)] and knockdown cells transduced with NET1 targeting shRNA [shown in all diagrams in
Figure 6 as NET1(-)] Figure 6B: TSPAN 1 expression in control cells transduced with non targeting shRNA (NT) cells and NET1 knockdown cells
transduced with NET1 targeting shRNA. Figure 6C. TGFBi expression in control cells transduced with non targeting shRNA (NT) and NET1
knockdown cells transduced with NET1 targeting shRNA. p < 0.0001 Figure 6D. CCL5 mRNA expression in control cells transduced with non
targeting shRNA (NT) and knockdown cells, p < 0.0001; Figure 6E. EGFR expression in untreated and LPA treated AGS cells. Figure 6F: PPARD
expression in untreated and LPA treated AGS cells. Figure 6G: IGF1R expression in LPA treated cells tranduced with non targeting shRNA control
cells and LPA treated NET1 knockdown cells transduced with NET1 targeting shRNA, p = 0.0001. Figure 6H. PIP5K3 expression in LPA treated cells
tranduced with non targeting shRNA control cells and LPA treated NET1 knockdown cells transduced with NET1 targeting shRNA. P < 0.0001.
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Page 8 of 10IGF1R (insulin like growth factor receptor 1) is over
expressed in malignant tissues and acts as an anti apop-
totic agent enhancing cell survival [50,51]. IGF1R has
been shown to be a predictor of poor outcome in
patients with GC [52]. Our study has shown LPA
mediated IGF1R expression was dependent on
NET1 expression. Coronas et al 2008 have suggested a
role for PIP5K3 (Phosphatidylinositol-3-phosphate/phos-
phatidylinositol 5-kinase, type III) in oncogenesis [53].
PIP5K3 has also been proposed as a mediator of EGFR
transcription function in bladder carcinoma [54]. Its role
in gastric oncogenesis is not yet clear, however our data
shows that LPA induced PIP5K3 expression is
NET1 dependent in GC.
Conclusion
In summary, we have shown that NET1 is a potent med-
iator and an important player in GC cell invasion. Sup-
pression of NET1 results in significantly reduced motility
and invasion of AGS GC cells in vitro. These traits are
essential for tumor metastasis, thereby supporting a role
for NET1 in the disease setting. This is also the first
report of the ‘NET1 transcriptome’,ag e n ee x p r e s s i o n
signature of GC invasion. As well as providing a func-
tional insight into the biology and signalling underpin-
ning NET1-mediated cell invasion, this dataset may
prove useful in the development of biomarkers for dis-
ease aggressiveness, or in providing targets for therapeu-
tic intervention. Genes involved in cellular differentiation
and proliferation, cell motility, and cell-cell adhesion are
up-regulated when high levels of NET1 are present, indi-
cating that NET1 drives these cellular processes that con-
tribute to the aggressiveness of GC. The specific
mechanisms require further investigation possibly across
other cell line models of GC but may very well serve as a
potential targets for GC therapies in the future.
GEO Microarray Data Accession: GSE26309
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